Why Do I Get Side Effects? Personalized (N-of-1) Trials for Statin Intolerance and the Nocebo Effect
Saved in:
| Main Authors: | James Philip Howard, Frances A. Wood, Darrel P. Francis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The MIT Press
2022-09-01
|
| Series: | Harvard Data Science Review |
| Online Access: | http://dx.doi.org/10.1162/99608f92.abc57f1b |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The impact of the nocebo effect on discontinuation of statin therapy due to myopathy in patients with cardiovascular disease – a review
by: Jakub Stanek, et al.
Published: (2024-11-01) -
Exploratory study of nocebo effect in senior medical students
by: Charalampos Pischos, et al.
Published: (2024-05-01) -
The effect of clinician-expressed empathy and nocebo-alleviating information on breast-cancer-patients' anxiety and side effects during active chemotherapy: A clinical feasibility study
by: Lara C. Gröschel, et al.
Published: (2025-06-01) -
Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
by: Zhuangqi Shi, et al.
Published: (2025-01-01) -
The Underestimated Significance of Conditioning in Placebo Hypoalgesia and Nocebo Hyperalgesia
by: Anne-Kathrin Bräscher, et al.
Published: (2018-01-01)